Dr. Alka Gandhi: Resolving the Case of Adverse Drug Event in Management of T2DM
CASE OVERVIEW DPP-4 inhibitors are an established class of oral antidiabetic agents for the treatment of type 2 diabetes. The most widely used among...
Metabolic Health Digest
Dr. Amit Gupta: a Case of Hyperglycemia Management in Elderly
CASE OVERVIEW The ADA recognizes that overtreatment of diabetes in eldelry population is common and should be avoided. “ Deintensification (or simplification) of complex...
Efficacy and safety of once-weekly Efpeglenatide vs. Placebo as monotherapy in patients with type 2 diabetes (AMPLITUDE-M)
Efpeglenatide is being subcutaneously administered once per week as a long-acting GLP-1 receptor agonist. Frias JP and colleagues conducted a study under the title...
Efficacy and safety of once-weekly Tirzepatide, a dual GIP/GLP-1 receptor agonist vs. placebo as monotherapy in people with type 2 diabetes (SURPASS-1)
With the increasing prevalence of diabetes, new treatment approaches are in need of time. Rosenstock J and colleagues conducted research under the title “Efficacy...
Fibrocalculous Pancreatic Diabetes: (FCPD)
A most common form of diabetes worldwide is Type 1 and Type 2 diabetes. Fibrocalculous pancreatic diabetes (FCPD) is a unique form of diabetes,...
Dr Faraz Farishta: a Rare Case of Hyperinsulinemic Hypoglycemia (Hirata’s Disease (IAH))
CASE OVERVIEW Insulin Autoimmune Syndrome (IAS)/ Hirata’s Disease (IAH) is a rare cause of hypoglycemia. Such case of 70-year old female was presented by...
